Minoxidil and finasteride topical solution is a scalp solution that combines two hair loss medicines in one bottle. A 2025 meta-analysis of trials in men found it improved hair density more than minoxidil alone [1], and the Indian pharmacy listing we checked marks it as a prescription medicine for men [9].
Every medical figure below is taken from a source listed at the end. Whether to use it is for the doctor who examines you to decide, and directions for use come from the label and the doctor, not from this page.
What Is Minoxidil and Finasteride Topical Solution?
Minoxidil is applied to the scalp for pattern hair loss in men and women [12]. Finasteride lowers DHT, the hormone that acts on hair follicles in male pattern hair loss [11]. The two act through different mechanisms [7].
There is no FDA-approved topical finasteride in the United States [8]. DermNet states that a topical formulation has been approved in India, without saying which product [11]. One Indian product, Morr F 5% from Intas Pharmaceuticals, contains minoxidil 5% with finasteride 0.1% [9].
Key points:
- A prescription scalp solution for men that combines minoxidil with finasteride. If you already use it without a prescription, have a doctor review it.
- No woman who is pregnant, breastfeeding, planning a pregnancy or of childbearing age should use or handle it. If you use it and your partner is in one of those groups, see a doctor about it now.
- The US regulator expects finasteride applied to the skin to reach the bloodstream, and has received reports of sexual and mood side effects with compounded products.
- A 2025 meta-analysis of trials in men found the combination improved hair density more than minoxidil alone. An earlier one found no significant difference.
Does the Combination Work Better Than Minoxidil Alone?
In men, the most recent pooled analysis says it does, with limits. A 2025 meta-analysis of seven randomised trials with 396 men found that the combination improved hair density more than minoxidil alone. The density result came from five trials with 170 men whose results varied widely. The authors rated it as moderate-certainty evidence, and the hair diameter and photographic results as low certainty. No trial ran longer than six months [1].
Two of the individual trials show what was tested:
- In a 24-week trial of 40 men, one solution containing finasteride 0.25% and minoxidil 3% was significantly better than minoxidil 3% alone for hair density, hair diameter and photographic assessment [2].
- In a six-month trial of 42 men, minoxidil 5% in the morning plus a finasteride 0.25% spray in the evening was the only arm whose hair density improved significantly from the start of the trial [7].
An earlier meta-analysis of finasteride with topical minoxidil found better photographic scores but no significant difference in hair density change, and said the best concentration still needed study [6].
In women, the evidence we found is one small trial in 30 postmenopausal women. Blood DHT fell in the women using the combination, which suggests the finasteride was absorbed, and for that reason the authors said it “should be reserved for postmenopausal women”. The combination did better than minoxidil alone for hair diameter [4].
What the Trials Used vs What Is Sold in India
The seven trials in the meta-analysis used two strengths of finasteride: 0.25% in four and 0.1% in three, including an Indian trial of minoxidil 5% with finasteride 0.1% [1]. Morr F 5% is the 0.1% strength [9]. The meta-analysis does not compare the two strengths, and its authors say head-to-head trials are needed to find the best one [1]. A lower strength is not a reason to apply more.
Minoxidil and Finasteride Topical Solution Side Effects
| Side effect | What is reported | Source |
|---|---|---|
| Scalp reactions | Itching, burning, stinging, irritation, redness, dryness or scaling. Contact dermatitis in 12 to 24% of cases in the combination trials | [5] [8] [1] |
| Unwanted hair away from the scalp, headache | Listed on the Indian product page | [9] |
| Temporary shedding | Listed for the first few weeks of use | [9] |
| Sexual side effects | In a phase 3 trial of a finasteride spray: 2.8% with the spray, 3.3% with placebo, 4.8% with the tablet. The Indian product page calls them rare. Reported to the FDA with compounded products: erectile dysfunction, decreased libido, testicular pain, with most reports saying the effects continued after stopping | [3] [9] [8] |
| Mood and sleep effects | In the same FDA reports: anxiety, depression, suicidal ideation, brain fog, fatigue, insomnia | [8] |
| Chest pain, rapid heartbeat, dizziness, signs of a severe allergic reaction | Stop and see a doctor immediately | [9] |
Topical does not mean it stays on the scalp. In April 2025 the FDA said that absorption of finasteride through the skin into the bloodstream is expected. Its alert covers compounded products, which are made up by a pharmacy or sold through telemedicine services and are not FDA-approved, including finasteride combined with minoxidil. It had received 32 reports between 2019 and 2024, and most said the effects continued after the product was stopped [8]. The FDA gave no rate, and reports of this kind do not prove that the product caused the effect. For the tablet, DermNet says the sexual side effects seen in trials resolved when treatment stopped [11], which differs from most of the FDA reports [8].
A phase 3 trial of a finasteride-only spray found much lower blood levels than with the tablet, as the comparison further down shows [3]. In the 40-man combination trial, blood DHT fell by about 5% and no systemic side effects were reported [2]. A review also describes a seven-day study in which a twice-daily 0.25% solution lowered blood DHT about as much as the tablet [5], so how much reaches the body appears to depend on the product.
Stop and see a doctor immediately if you notice chest pain, a rapid heartbeat, dizziness or signs of a severe allergic reaction, as the Indian product page says [9]. Tell a doctor about any change in mood or sexual function, the effects described in the FDA reports [8].
Who Should Not Use It
No woman who is pregnant, breastfeeding, planning a pregnancy or of childbearing age should use or handle it. That is the wording of the Indian product page [9]. Finasteride is contraindicated in pregnancy because of the potential to cause abnormalities of a male fetus, and the FDA warns that a topical product can reach other people, specifically women, through transfer of the applied product [8]. Minoxidil is also best avoided in pregnancy and breastfeeding [12].
If you use it and your partner is pregnant, could become pregnant or is trying to conceive, see a doctor about it now. The product page says such women should avoid contact with the solution or the treated scalp until it has completely dried [9]. Neither it nor the FDA says anything about pillows or bedding, or when the risk of transfer ends [8] [9], so do not treat dry as safe.
If you are planning to have children, say so before you start. For the tablet, DermNet says finasteride is not recommended in men who are subfertile, and that some doctors check sperm counts before starting [11]. The phase 3 spray trial excluded men with a history of infertility [3]. None of the sources we read covers exposure of a partner through semen, so ask the doctor directly.
The sources also name these groups:
- Anyone under 18 [9]
- Anyone with a history of heart disease or low or high blood pressure, who should talk to a doctor first [9]
- Anyone whose scalp is shaved, inflamed, infected, irritated or painful [9]
- Anyone with sudden or unexplained hair loss, which needs a diagnosis first [9]
For women with pattern hair loss, finasteride is not indicated [11]. DermNet describes minoxidil as used for female pattern hair loss, and a doctor decides whether it suits you [12].
Topical Finasteride vs Finasteride Tablets
A phase 3 trial compared a finasteride spray with the 1 mg tablet and with placebo for 24 weeks at 45 sites in Europe. It randomised 458 men, and 323 completed it. The spray contained finasteride only, with no minoxidil, and the sources do not link it to any product sold in India [3].
| Finasteride spray | Finasteride 1 mg tablet | |
|---|---|---|
| Change in target-area hair count at 24 weeks | 20.2 hairs (placebo 6.7) | 21.1 hairs |
| Peak finasteride level in blood | More than 100 times lower than with the tablet | The comparison point |
| Fall in blood DHT, a sign of how much reaches the body | 34.5% | 55.6% |
| Treatment-related sexual side effects | 2.8% (placebo 3.3%) | 4.8% |
| Regulatory status | No FDA-approved topical product [8] | Indicated for men with male pattern hair loss [11] |
Figures in the table are from the trial [3] unless marked.
The spray lowered blood DHT less than the tablet, and the trial’s authors say this makes sexual side effects less likely [3]. The FDA reports point the other way [8].
Minoxidil and Finasteride Topical Solution Price in India
One large Indian pharmacy listed 21 minoxidil and finasteride topical products at ₹617 to ₹1,265.50 when we checked on 13 October 2026. Most were 60 ml bottles, and all but one were marked as prescription items [10]. Morr F 5% (60 ml) was listed at an MRP of ₹850 [9].
Do not buy it without a prescription. If you already have a bottle, have a doctor review it before you continue. The pharmacy pages mark these products as prescription items [9] [10], and the FDA says consumers should consult health care providers about the risks [8].
What the Combination Will Not Do
It is not a short course. With topical minoxidil, hair normally goes back to how it looked before treatment within three or four months of stopping [12]. For the finasteride tablet, DermNet says treatment probably has to continue indefinitely to keep the benefit [11]. The combination itself has not been studied for longer than six months [1].
It is slow. The trials measured results at three to six months [1], and the Indian product page says it may take several months to notice less hair loss [9].
We found no evidence that it restores a bare scalp. The trials measured changes in hair density and hair diameter [1] [2].
You need a diagnosis first. The product page itself warns against using it for sudden or unexplained hair loss [9]. Our guides to minoxidil and DHT blockers cover each medicine on its own.
Frequently Asked Questions
What is minoxidil and finasteride topical solution used for?
It is used for male pattern hair loss. The Indian product page we checked lists it for men, as a prescription medicine [9].
Does it work better than minoxidil alone?
A 2025 meta-analysis of seven randomised trials with 396 men found greater improvement in hair density with the combination. That result came from five of the trials, varied widely between them, and was rated as moderate-certainty evidence [1]. An earlier meta-analysis found better photographic scores but no significant difference in hair density [6].
What are the side effects of minoxidil and finasteride topical solution?
Scalp reactions such as itching, burning, irritation and redness are the ones most often listed [5] [8]. In a phase 3 trial of a finasteride spray, sexual side effects were reported by 2.8% of men, against 3.3% on placebo [3]. The FDA has received reports of sexual and mood side effects with compounded products, and most said the effects continued after stopping [8]. Stop and see a doctor immediately for chest pain, a rapid heartbeat, dizziness or signs of a severe allergic reaction [9].
Can women use minoxidil and finasteride topical solution?
Not if you are pregnant, breastfeeding, planning a pregnancy or of childbearing age. The Indian product page says such women must not use or even handle it [9], so do not share a partner’s bottle. Finasteride is not indicated for women with hair loss [11], and the authors of the one small trial in women said it should be reserved for postmenopausal women because it may be absorbed through the skin [4]. DermNet describes minoxidil as used for female pattern hair loss, and a doctor decides whether it suits you [12].
Is it safe to use if my partner is pregnant or we are trying for a child?
See a doctor about it now. The product page says women who are pregnant or planning a pregnancy must not handle the product and should avoid the treated scalp until it has completely dried [9], and the FDA warns of transfer to others [8]. No source we read covers bedding or exposure through semen. For the tablet, some doctors check sperm counts in men planning to have children [11].
Is topical finasteride safer than the tablet?
In one phase 3 trial of a finasteride spray, blood DHT fell 34.5%, against 55.6% with the tablet, and sexual side effects were reported by 2.8% and 4.8% of men [3]. The FDA still says absorption through the skin is expected and has received reports of side effects [8]. It depends on the product [5].
How long does it take to work, and what happens if I stop?
The trials measured results at three to six months [1]. With topical minoxidil, hair normally goes back to how it looked before treatment within three or four months of stopping [12], and for the finasteride tablet DermNet says treatment probably has to continue indefinitely to keep the benefit [11].
Get Your Hair Loss Assessed
Which treatment suits you, if any, depends on the cause and stage of your hair loss. You can book a consultation at any of our 13 clinics in India and Dubai, or start with the baldness calculator.
If you already have bare areas, a hair transplant is one option a doctor may discuss. A qualified doctor performs every hair transplant at Assure Clinic. Pricing is on a Full Head Results basis, from ₹2 lakh to ₹15 lakh depending on the extent of loss. The hair transplant cost calculator gives you an estimate.
Sources
- Li Y, Huang Q, Zhou Z, Zhang Y. Comparing minoxidil-finasteride mixed solution with minoxidil solution alone for male androgenetic alopecia: a systematic review and meta-analysis of randomized controlled trials. Front Med (Lausanne). 2025;12:1632139. full text, PMC12537375
- Suchonwanit P, et al. A randomized, double-blind controlled study of topical 0.25% finasteride admixed with 3% minoxidil vs. 3% minoxidil solution in male androgenetic alopecia. J Eur Acad Dermatol Venereol. 2018;32(12):2257-2263. PubMed 29972712
- Piraccini BM, et al. Efficacy and safety of topical finasteride spray solution for male androgenetic alopecia: a phase III, randomized, controlled clinical trial. J Eur Acad Dermatol Venereol. 2022;36(2):286-294. full text, PMC9297965
- Suchonwanit P, Iamsumang W, Rojhirunsakool S. Efficacy of Topical Combination of 0.25% Finasteride and 3% Minoxidil Versus 3% Minoxidil Solution in Female Pattern Hair Loss. Am J Clin Dermatol. 2019;20(1):147-153. PubMed 30206824
- Gupta AK, Talukder M. Topical finasteride for male and female pattern hair loss: Is it a safe and effective alternative? J Cosmet Dermatol. 2022;21(5):1841-1848. PubMed 35238144
- Chen L, et al. The Efficacy and Safety of Finasteride Combined with Topical Minoxidil for Androgenetic Alopecia: A Systematic Review and Meta-analysis. Aesthetic Plast Surg. 2020;44(3):962-970. PubMed 32166351
- Rossi A, Caro G. Efficacy of the association of topical minoxidil and topical finasteride compared to their use in monotherapy in men with androgenetic alopecia. J Cosmet Dermatol. 2024;23(2):502-509. PubMed 37798906
- US Food and Drug Administration. FDA alerts health care providers, compounders and consumers of potential risks associated with compounded topical finasteride products. Current as of 22 April 2025. fda.gov
- Apollo Pharmacy. Morr F 5% Solution, product page, read 13 October 2026. apollopharmacy.in
- Apollo Pharmacy. Minoxidil + finasteride, product listing, read 13 October 2026. apollopharmacy.in
- DermNet. Finasteride. dermnetnz.org
- DermNet. Minoxidil solution. Updated November 2025. dermnetnz.org
